2016 VAM: 1003 - How Translational Research is Shifting the Treatment Paradigm from Symptom Management to Cure
The major goal of the course is to present translational research to be understood by a broader audience.
AMA PRA Category 1 Credits™: 2.50
Credit must be claimed by May 31, 2018. Any credit request on or after June 1, 2018 will be subject to an administrative fee.
Allied Health Professionals
Upon completion of this session, participants should be able to:
1. Discuss how genetic factors and the environment interact to determine allergic sensitization
2. Identify potential targets for prevention and treatment
3. Discuss different types of treatment for allergic diseases
Rosa Bacchetta, MD, Stanford School of Medicine, Stanford, CA
Nicholas W. Lukacs, PhD, University of Michigan, Ann Arbor, MI
Natalija Novak, MD, University of Bonn, Bonn, Germany
Jennifer M. Puck, MD, University of California, San Francisco, CA
Rudolf Valenta, MD, Medical University of Vienna AKH, Wien, Austria
- 2.50 AttendanceAttendance credit.
- 2.50 CECE credit.
- 2.50 CMECME credit.